Indian bioinformatics firm Jubilant Biosys announced that it has in-cluded Agilent’s Microarray 60mer Probe Identifiers in its PathArt signaling and metabolic pathways database.

PathArt contains over 900 signaling and metabolic pathways and covers nine physiologies and 17 disease states. According to the firm, users of the Agilent microarrays will be able to map and add biological relevance to the results of their experiments on PathArt.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

In Science this week: genetic overlap among many psychiatric disorders, and more.

The Economist writes that an increasing number of scientific journals don't do peer review.